Schisantherin C is primarily studied for its potential neuroprotective and anti-inflammatory effects. It has shown promise in supporting cognitive health by modulating pathways involved in neuronal damage and oxidative stress. Research suggests it may help in delaying the progression of neurodegenerative conditions such as Alzheimer’s disease by inhibiting the aggregation of amyloid-beta peptides. Additionally, it exhibits hepatoprotective properties, making it relevant in liver health, particularly in protecting against drug-induced or toxin-related liver injury. Its antioxidant activity also contributes to cellular protection against free radical damage, which may have broader implications in aging and chronic disease prevention. Preliminary in vitro studies have demonstrated inhibitory effects on the growth of certain cancer cells, indicating potential for oncology research. Most applications are still within preclinical research, focusing on therapeutic development in neurology, hepatology, and oncology.